Business Wire

NY-LUXOFT-HOLDING,-INC

Share
Luxoft Acquires Autonomous Drive and Connected Mobility Specialist Objective Software GmbH

Luxoft Holding, Inc (NYSE:LXFT), a global IT service provider, announces the acquisition of Objective Software GmbH , a provider of software development services and IP based solutions for autonomous vehicles, Advance Driver Assisted Systems (ADAS), high-accuracy positioning, innovative mobility and smart city applications.

Objective implements its advanced technology solutions in the automotive sector, with a focus on connected cars and autonomous drive services for leading Original Equipment Manufacturers (OEMs) and suppliers.

This acquisition expands Luxoft's ADAS, Autonomous Drive and Connected Mobility practices and illustrates a commitment to meet the growing demand for these services. Upon completion of this transaction, Luxoft gains access to a range of IP-based solutions developed by Objective, including a tele-operated driving platform, cloud-based autonomous car-sharing, automotive cybersecurity solutions and a Lidar-based automated parking scanner. These solutions, combined with Objective's domain expertise, will enhance Luxoft's design, development and implementation of next-generation software that empowers our clients to succeed in the mobility revolution.

Given close synergies with our service-led model, backed by in-house application development, we anticipate opportunities to significantly scale Objective's existing projects in autonomous driving and connected mobility. In particular, the acquisition further strengthens our presence in Munich where we intend to expand software development services for highly automated driving with OEMs and Tier1s, thereby delivering software effectively across the full value chain.

"This acquisition reinforces the strong foundation on which our automotive practice has grown in recent years and future-proofs our capabilities," said Dmitry Loschinin, President and CEO of Luxoft . "Objective has established a strong footprint with major German OEMs, and we believe these synergies will allow us to deliver more strategic value to our clients. We look forward to working with Objective's team and enhancing our existing offerings, as we develop the tools that are enabling the mobility revolution."

Through Luxoft's global ecosystem of 42 delivery centers, this acquisition will expand the scalability and reach of Objective's offering within its existing footprint of leading German OEMs and their suppliers. It also strengthens Luxoft's delivery capabilities in Germany, while adding a new office in Italy.

"There is huge potential for Luxoft to grow Objective's solutions to benefit new and existing customers," said Clemens Dannheim, the co-CEO of Objective . "Both the Company's culture and like-minded approach to building advanced automotive solutions make for a well matched acquisition. With advanced connected mobility services and autonomous cars already on our streets, we wanted to take this opportunity to scale our business and effect the changes revolutionizing the automotive industry on a global scale."

About Luxoft

Luxoft (NYSE:LXFT) is a global IT service provider of innovative technology solutions that delivers measurable business outcomes to multinational companies. Its offerings encompass strategic consulting, custom software development services, and digital solution engineering. Luxoft enables companies to compete by leveraging its multi-industry expertise in the financial services, automotive, communications, and healthcare & life sciences sectors. Its managed delivery model is underpinned by a highly-educated workforce, allowing the Company to continuously innovate upwards on the technology stack to meet evolving digital challenges.

Luxoft has more than 12,900 staff across 42 cities in 21 countries within five continents, with its operating headquarters office in Zug, Switzerland. For more information, please visit www.luxoft.com .

About Objective

Objective Software GmbH is an IT company that offers advanced solutions for the future: Areas such as automotive, autonomous vehicles, teleoperated driving, high-precision positioning as well as innovative mobility or smart city applications are among the company's areas of expertise. The company's standards are high, which is why it is committed to effective and immediate action, clear goals and a visionary approach. The Objective-motor drives it: The passion and creativity of the team, coupled with excellent team spirit and organization. With over 100 employees spread over several locations in Europe, the teams offer exciting projects with global Original Equipment Manufacturers and Tier one Suppliers.

Further information about the company and its projects can be found at www.objective.de .

Forward-Looking Statements

This news release of Luxoft Holding, Inc ("Luxoft") contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements include information about possible or assumed future results of our business and financial condition, as well as the results of operations, liquidity, plans and objectives. In some cases, you can identify forward-looking statements by terminology such as "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "expect," "predict," "potential," or the negative of these terms or other similar expressions. These statements are subject to, without limitation, the risk factors discussed under the heading "Risk Factors" in Luxoft's Annual Report on Form 20-F for the year ended March 31, 2017 and other documents filed with or furnished to the Securities and Exchange Commission by Luxoft. Except as required by law, Luxoft undertakes no obligation to publicly update any forward-looking statements for any reason after the date of this news release whether as a result of new information, future events or otherwise.

Contact:

Luxoft Holding, Inc
Investor Inquiries
Tracy Krumme
Vice President, Investor Relations
212.964.9900 x2460
IR@luxoft.com
or
Media Inquiries
Robert Maccabe
Director, Public Relations
t: +44 (0)20 3828 2346; m:+44 7950 517 836
Press@luxoft.com
Twitter: @Luxoft
or
Julia Maehner
Marketing Specialist
T: +49 89 710 501 26
Julia.maehner@objective.de
Twitter: @objectiveSW

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SBC Medical added to membership of Russell 3000® Index28.6.2025 01:30:00 CEST | Press release

SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250608244276/en/ Yoshiyuki Aikawa-Director (Chairman), CEO Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000®Index as well as the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to

Altimetrik and SLK Software Join Forces to Create an AI-First Engineering Services Powerhouse27.6.2025 22:44:00 CEST | Press release

Altimetrik, a pure-play AI, Data and Digital engineering solutions company, today announced the signing of a definitive agreement to acquire SLK Software (“SLK”), a global technology services firm focused on delivering AI, intelligence automation and analytics solutions. The acquisition will further strengthen Altimetrik’s end-to-end enablement services and expand its customer reach, with a clear path to accelerate towards Altimetrik’s goal of reaching $1billion in annual revenue. The transaction remains subject to customary closing conditions and is expected to close in the second half of 2025. Financial details were not disclosed. Founded in 2000, SLK is recognized as a leader in the tech industry, and for its commitment to create innovative digital solutions. This strategic acquisition will significantly enhance the scale of Altimetrik’s capabilities, bringing together Altimetrik’s AI-first, platform-native engineering model and SLK’s full technology services stack that will further

Andersen Consulting udvider sine kompetencer inden for forretningstransformation med tilføjelsen af The Clearing27.6.2025 16:48:00 CEST | Pressemeddelelse

Andersen Consulting udbygger sin platform med samarbejdsfirmaet The Clearing, som er en managementkonsulentvirksomhed med speciale i organisatorisk omstilling og lederudvikling. The Clearing blev stiftet i 2009 og rådgiver kunder om komplekse udfordringer ved at afstemme ledelse, strategi, kultur og drift. Firmaet arbejder med føderale agenturer, virksomheder og nonprofitorganisationer med henblik på at skabe målbare forandringer på tværs af forskellige interessenter til gavn for en leders vision og strategi. Med dyb erfaring inden for flere sektorer, herunder national sikkerhed, sundhedspleje og finansielle tjenester, leder The Clearings unikke blanding af talent med ekspertise inden for organisationsudvikling, dataanalyse og visuel rådgivning forretningstransformationer i stor skala og arbejder sammen med kunder og eksperter for at sikre, at rådgivning omsættes til implementering. "Vi leverer transformative resultater, der ikke kun er i overensstemmelse med strategiske mål, men også

PRD Therapeutics Announces Initiation of First-in-Human Study for PRD00127.6.2025 16:00:00 CEST | Press release

PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting homozygous familial hypercholesterolemia (HoFH) and metabolic dysfunction associated fatty liver disease (MASH/MASLD), today announced that the company recently initiated dosing in a First-in-Human (FIH) clinical trial of PRD001, a first-in-class SOAT2 (formerly known as ACAT2) selective inhibitor. “We are excited to initiate dosing in this clinical trial of PRD001. Many clinical trials have been conducted on SOAT1/2 dual or SOAT1 selective inhibitors, but this is the first clinical trial of an SOAT2 selective inhibitor” said Kanji Hosoda, Ph.D., CEO and co-founder of PRD Therapeutics. “Several results with SOAT1 or 2 knockout mice have been published, suggesting that knocking out or inhibiting only SOAT2 is crucial to demonstrate safety and efficacy. PRD001 is the world's first and only SOAT2-selective inhibitor and is expected to exhibit safety and efficacy in hu

STEMCELL Technologies Introduces STEMprep™ Tissue Dissociator System to Accelerate Research Discoveries27.6.2025 14:00:00 CEST | Press release

New instrument automates tissue processing for researchers in cancer, immunology and other science fields To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250627342791/en/ To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. “Tissue dissociation is incredibly important for making advancements in research fields, like cancer and immunology, yet

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye